Real-time enrollment status for this intraductal papillary mucinous neoplasm clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:09 PM UTC
| NCT Number | NCT07216521 |
| Recruiting Status | Recruiting |
| Condition | Intraductal Papillary Mucinous Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 2,000 participants |
| Active Locations | 8 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | October 14, 2025 (Oct 14, 2025) |
As of July 13, 2026: Clinical trial NCT07216521 is currently recruiting participants. This clinical trial study for intraductal papillary mucinous neoplasm is actively seeking new participants at 8 locations across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216521 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216521 was last updated Oct 14, 2025 (October 14, 2025). HelloStudys verifies this status automatically.